UBIO
Proshares UltraPro NASDAQ Biotechnology
UBIO
UBIO
Delisted
UBIO was delisted on the 27th of March, 2020.
7 hedge funds and large institutions have $2.14M invested in Proshares UltraPro NASDAQ Biotechnology in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
–
Holders Change %
0%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
3
Closed
2
Calls
$2.85M
Puts
$856K
Net Calls
+$1.99M
Net Calls Change
+$1.79M
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$569K |
| 2 |
Jane Street
New York
|
+$263K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$48.3K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$18K |
Top Sellers
| 1 |
VF
Virtu Financial
New York
|
-$2.25M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$558K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$212K |
| 4 |
Morgan Stanley
New York
|
-$5.61K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $641K | +$263K | +9,052 | +69% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $569K | +$569K | +19,693 | New |
|
|
VF
3
Virtu Financial
New York
| $429K | -$2.25M | -77,824 | -84% |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $396K | -$558K | -19,208 | -58% |
|
|
5
UBS Group
Zurich,
Switzerland
| $76K | +$48.3K | +1,666 | +174% |
|
|
6
Simplex Trading
Chicago,
Illinois
| $18K | +$18K | +637 | New |
|
|
7
Morgan Stanley
New York
| $11K | -$5.61K | -200 | -34% |
|
|
8
Citadel Advisors
Miami,
Florida
| – | -$212K | -9,976 | Closed |
|